Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

New Imaging Technology Could Reveal Cellular Mysteries

By BiotechDaily International staff writers
Posted on 21 May 2013
Researchers have fused two biologic imaging technologies, creating a new approach to determine how healthy cells turn malignant.

“Let’s say you have a large population of cells,” said Dr. Corey Neu, an assistant professor in Purdue University’s (West Lafayette, IN, USA) Weldon School of Biomedical Engineering. “Just one of them might metastasize or proliferate, forming a cancerous tumor. We need to understand what it is that gives rise to that one bad cell.”

This new development makes it possible to simultaneously evaluate the mechanical and biochemical characteristics of cells, which could provide new clues into disease processes, according to biomedical engineering postdoctoral fellow Charilaos Mousoulis. Being able to study a cell’s internal mechanisms in precise detail would in all probably provide insights into the physical and biochemical responses to its environment. The technology, which combines an atomic force microscope and nuclear magnetic resonance system (MRI), could help researchers study individual cancer cells, for example, to uncover mechanisms leading up to cancer metastasis for research and diagnostics.

The prototype’s capabilities were demonstrated by taking nuclear magnetic resonance spectra of hydrogen atoms in water. Findings represent a proof of concept of the technology and were published in a research paper that appeared online April 11, 2013, in the journal Applied Physics Letters. “You could detect many different types of chemical elements, but in this case hydrogen is nice to detect because it’s abundant,” Dr. Neu said. “You could detect carbon, nitrogen and other elements to get more detailed information about specific biochemistry inside a cell.”

An atomic force microscope (AFM) uses a tiny vibrating probe called a cantilever to provide data about substances and surfaces on the scale of nanometers (billionths of a meter). Because the instrument enables scientists to visualize objects far smaller than possible using light microscopes, it could be suitable for studying molecules, cell membranes and other biologic structures.

However, the AFM does not provide information about the chemical and biologic properties of cells. Therefore, the researchers constructed a metal microcoil on the AFM cantilever. An electrical current is passed though the coil, causing it to exchange electromagnetic radiation with protons in molecules within the cell and inducing another current in the coil, which is detected.

The Purdue researchers performed “mechanobiology” experiments to find out how forces exerted on cells influence their behavior. In work focusing on osteoarthritis, their research includes the study of cartilage cells from the knee to determine how they interact with the complex matrix of structures and biochemistry between cells.

Future research might include studying cells in microfluidic chambers to assess how they respond to specific drugs and environmental changes. A US patent application has been filed for the concept.

Related Links:
Purdue University



Channels

Genomics/Proteomics

view channel
Image: In mice, mitochondria (green) in healthy (left) and Mfn1-deficient heart muscle cells (center) are organized in a linear arrangement, but the organelles are enlarged and disorganized in Mfn2-deficient cells (right) (Photo courtesy of the Rockefeller Press).

Cell Biologists Find That Certain Mitochondrial Diseases Stem from Coenzyme Q10 Depletion

A team of German cell biologists has linked the development of certain mitochondrial-linked diseases to depletion of the organelles' pool of coenzyme Q10 brought about by mutation in the MFN2 gene, which... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.